Latest News and Press Releases

Amsterdam, The Netherlands - 10 January 2018 Esperite N.V. (Euronext: ESP, "Esperite" or "the Group") announces that today the 12th Tranche of EUR 250,000 is issued as a private placement of 25...

Amsterdam, the Netherlands - 8 January 2018 ESPERITE N.V. (Euronext: ESP, 'ESPERITE', or 'the Group') declares the conversion of a portion of the EUR 2'025'000 loan note of CEO Frederic Amar...

                      Amsterdam, the Netherlands - 5 January 2018 ESPERITE N.V. (Euronext: ESP, 'ESPERITE', or 'the Group') declares the issuance of a convertible loan note of EUR 400'000 to CEO...

Further support of Esperite's strategy, commercial activities and development of innovative technologies in the field of genetics and regenerative medicines   Amsterdam, the Netherlands - 22...

Amsterdam, the Netherlands - 27 November 2017 Esperite is pleased to announce that it has nominated Accon AVM as external auditor for the financial statements 2017. About ESPERITE ESPERITE is a...

Esperite has taken all the necessary measures after the difficult end of the first semester. The company invests in its technology and prepares to grow again. Amsterdam, The Netherlands - 17...

Amsterdam, The Netherlands - 9 November 2017 Esperite N.V. (Euronext: ESP, "Esperite" or "the Group") announces that today the Tenth Tranche of EUR 250,000 is issued as a private placement of...

Amsterdam, The Netherlands - 9 November 2017 Esperite N.V. (Euronext: ESP, "Esperite" or "the Group") announces that today the Tenth Tranche of EUR 250,000 is issued as a private placement of 25...

Amsterdam, The Netherlands - 30 October 2017 Esperite N.V. (Euronext: ESP, "Esperite" or "the Group") announces that today the Ninth Tranche of EUR 250,000 is issued as a private placement of 25...

Amsterdam, The Netherlands - 10 October 2017 As of today, EUR 2,700,000 of notes out of the total commitment amounting to EUR 9 million have been converted into shares and EUR 112,500 of warrants...